NASDAQ:IXHL

Incannex Healthcare (NASDAQ: IXHL) Stock: FDA Fast Track Catalyst, Nasdaq Compliance Clock, and the Latest Forecasts as of Dec. 15, 2025

Incannex Healthcare Inc. is back on traders’ radar heading into mid-December, with the stock hovering around $0.42 in early Monday pricing on December 15, 2025, after closing near $0.40 in the prior session.

15 December 2025

NASDAQ:IXHL·Stock Market

Incannex Healthcare (IXHL) Stock Soars on FDA Fast Track: December 2025 Outlook, Forecast & Key Risks

Incannex Healthcare Inc. is back on traders’ radar after the U.S. Food and Drug Administration granted Fast Track designation to its lead sleep-apnoea drug candidate, IHL‑42X. The move caps a busy 2025 that also brought strong Phase 2 data in sleep apnoea and psilocybin-assisted therapy, a major clean-up of warrant overhang, and a fight to keep the company’s Nasdaq listing alive. SEC+1

4 December 2025